{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:53Z","timestamp":1786997933342,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.urolonc.2017.09.009","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T02:16:15Z","timestamp":1507688175000},"page":"9.e11-9.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes"],"prefix":"10.1016","volume":"36","author":[{"given":"Bishoy M.","family":"Faltas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee L.","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2017.09.009_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.2014.987662","article-title":"Novel molecular targets for urothelial carcinoma","volume":"19","author":"Faltas","year":"2015","journal-title":"Expert Opin Ther Targets"},{"issue":"21","key":"10.1016\/j.urolonc.2017.09.009_bib2","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5 B","key":"10.1016\/j.urolonc.2017.09.009_bib3","first-page":"137","article-title":"A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma","volume":"113","author":"Pond","year":"2014","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.urolonc.2017.09.009_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","article-title":"Liver resection for colorectal metastases","volume":"15","author":"Fong","year":"1997","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2017.09.009_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10434-000-0643-3","article-title":"Survival after resection of multiple hepatic colorectal metastases","volume":"7","author":"Weber","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2017.09.009_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/thoraxjnl-2011-200015","article-title":"Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial","volume":"67","author":"Treasure","year":"2012","journal-title":"Thorax"},{"issue":"8 Suppl","key":"10.1016\/j.urolonc.2017.09.009_bib7","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.urolonc.2017.09.009_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"10","key":"10.1016\/j.urolonc.2017.09.009_bib9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"21","key":"10.1016\/j.urolonc.2017.09.009_bib10","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.09.009_bib11","unstructured":"Treatment of metastatic urothelial cancer of the bladder and urinary tract. http:\/\/www.uptodate.com\/contents\/treatment-of-metastatic-urothelial-cancer-of-the-bladder-and-urinary-tract?topicKey=ONC%2F3000&elapsedTimeMs=4&source=see_link&view=print&displayedView=full%23. Accessed September 28, 2017."},{"issue":"6 suppl 4","key":"10.1016\/j.urolonc.2017.09.009_bib12","first-page":"S228","article-title":"Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy","volume":"3","author":"Svatek","year":"2009","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.urolonc.2017.09.009_bib13","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/01.ju.0000067601.29966.4a","article-title":"Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?","volume":"169","author":"Sweeney","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2017.09.009_bib14","first-page":"631","article-title":"Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30\/05)","volume":"55","author":"Kim","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2017.09.009_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.eururo.2008.11.039","article-title":"Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30\/05)","volume":"55","author":"Lehmann","year":"2009","journal-title":"Eur Urol"},{"issue":"39","key":"10.1016\/j.urolonc.2017.09.009_bib16","first-page":"631","article-title":"Surgical resection of urological tumor metastases following medical treatment","volume":"109","author":"Heidenreich","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.urolonc.2017.09.009_bib17","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1016\/S1166-7087(08)74556-1","article-title":"Y-a-t-il une place pour la chirurgie dans les tumeurs uroth\u00e9liales m\u00e9tastas\u00e9es\u202f?","volume":"18","author":"Lebret","year":"2008","journal-title":"Progr\u00e8s en Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2017.09.009_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.juro.2013.11.004","article-title":"Outcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in Japan","volume":"191","author":"Abe","year":"2014","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2017.09.009_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000099823.60465.e6","article-title":"Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience","volume":"171","author":"Siefker-Radtke","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2017.09.009_bib20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.eururo.2008.12.011","article-title":"Is metastasectomy for urothelial carcinoma worthwhile?","volume":"55","author":"Herr","year":"2009","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2017.09.009_bib21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cncr.29134","article-title":"The rise in metastasectomy across cancer types over the past decade","volume":"121","author":"Bartlett","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2017.09.009_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2009.05.008","article-title":"Complications following radical cystectomy for bladder cancer in the elderly","volume":"56","author":"Froehner","year":"2009","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2017.09.009_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1227\/NEU.0b013e31820c0441","article-title":"Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors","volume":"68","author":"Lassen","year":"2011","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.urolonc.2017.09.009_bib24","first-page":"1","article-title":"Urological cancer metastasis to the brain: When should we resect?\u2014Abstract","volume":"5","author":"Klaassen","year":"2012","journal-title":"UroToday Int J"},{"issue":"1","key":"10.1016\/j.urolonc.2017.09.009_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jso.23371","article-title":"Hepatic resection for colorectal metastases","volume":"109","author":"Frankel","year":"2014","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2017.09.009_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000658-198005000-00009","article-title":"Major hepatic resections for metastatic colorectal cancer","volume":"191","author":"Adson","year":"1980","journal-title":"Ann Surg"},{"issue":"29","key":"10.1016\/j.urolonc.2017.09.009_bib27","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","article-title":"Actual 10-year survival after resection of colorectal liver metastases defines cure","volume":"25","author":"Tomlinson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2017.09.009_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1477-2574.2009.00143.x","article-title":"Open liver resection for colorectal metastases: better short- and long-term outcomes in patients potentially suitable for laparoscopic liver resection","volume":"12","author":"Welsh","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.urolonc.2017.09.009_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11934-012-0293-6","article-title":"The role of metastasectomy in renal cell carcinoma in the era of targeted therapy","volume":"14","author":"Ljungberg","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2017.09.009_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.urolonc.2013.05.012","article-title":"Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: a review","volume":"32","author":"Masterson","year":"2014","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2017.09.009_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/BLC-170108","article-title":"Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis","volume":"3","author":"Patel","year":"2017","journal-title":"Bladder cancer"},{"issue":"29","key":"10.1016\/j.urolonc.2017.09.009_bib32","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2016.66.7352","article-title":"Efficacy of high-intensity local treatment for metastatic urothelial carcinoma of the bladder: a propensity score\u2013weighted analysis from the National Cancer Data Base","volume":"34","author":"Seisen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.09.009_bib33","first-page":"1","article-title":"Clonal evolution of chemotherapy-resistant urothelial carcinoma","volume":"October","author":"Faltas","year":"2016","journal-title":"Nat Genet"},{"issue":"15 Supplement","key":"10.1016\/j.urolonc.2017.09.009_bib34","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1158\/1538-7445.AM2015-4745","article-title":"Precision cancer medicine program for whole-exome sequencing of metastatic tumors reveals biomarkers of response","volume":"75","author":"Beltran","year":"2015","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.urolonc.2017.09.009_bib35","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-07-1264","article-title":"Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"issue":"10031","key":"10.1016\/j.urolonc.2017.09.009_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:09:26Z","timestamp":1761041366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917304726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1078143917304726"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.09.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}